How Pharma Must Rethink Omnichannel Engagement

In this episode of Pharma Talks, Nataliya Andreychuk sits down with Yacin Marzouki for an honest conversation about why omnichannel in pharma still feels more complicated than it should be.The discussion goes beyond tools and tactics. Nataliya and Yacin explore blind spots inside pharma teams, the shift toward a true business-to-healthcare mindset, and what omnichannel maturity actually looks like in practice.Key topics explored in this episode:Omnichannel strategies in pharma need to evolve for success.Understanding HCPs' needs is crucial for effective engagement.Blind spots in data and insights hinder omnichannel effectiveness.Content strategy must be connected across all channels.Technology alone cannot solve omnichannel challenges.Local differences impact omnichannel strategies significantly.Emotional tech and empathy are the future of engagement.Chapters00:00 Introduction to Omnichannel in Pharma 02:28 Guest Introduction and Background 05:20 Identifying Blind Spots in Pharma 11:57 Understanding HCP Needs and Engagement 16:12 Maturity Levels of Omnichannel Strategies 21:04 The Role of Content and Technology 28:45 Rapid Fire Round: Hot or NotListen in for sharp insights, real-world experience, and a rapid-fire round that challenges some of omnichannel’s most common assumptions.Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ ***Follow Viseven, Nataliya, and Fredrik in social media:https://www.linkedin.com/company/viseven/https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/fredrikholmboe/ ***🔗 Links for more insights:https://viseven.com/ai-data/https://viseven.com/healthcare-data-analytics/https://viseven.com/ai-medical-affairs/https://viseven.com/list-of-ai-mistakes-pharma-companies-make/